MINDMAZE THERAPEUTICS HOLDING SA Market Cap ($28.56 Million)
Market Cap & Net Worth: MINDMAZE THERAPEUTICS HOLDING SA (MMTX)
MINDMAZE THERAPEUTICS HOLDING SA market cap. MINDMAZE THERAPEUTICS HOLDING SA (SW:MMTX) has a market capitalization of $28.56 Million (CHF22.59 Million) as of November 4, 2026. Listed on the SW stock exchange, this Switzerland-based company holds position #23771 globally and #206 in its home market, demonstrating a -13.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MINDMAZE THERAPEUTICS HOLDING SA's stock price CHF0.14 by its total outstanding shares 169993750 (169.99 Million). Also see MMTX operating cash flow for how efficiently the company converts equity into cash flow.
MINDMAZE THERAPEUTICS HOLDING SA Market Cap History (2025–2026)
MINDMAZE THERAPEUTICS HOLDING SA market cap history from 2025 to 2026. Data shows growth from $408.34 Million to $29.92 Million (0.00% CAGR). Check MMTX share price today for real-time trading data and today's change.
MINDMAZE THERAPEUTICS HOLDING SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MINDMAZE THERAPEUTICS HOLDING SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore MMTX shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
636.05x
MINDMAZE THERAPEUTICS HOLDING SA's market cap is 636.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $408.34 Million | $642.00K | -$9.91 Million | 636.05x | N/A |
Competitor Companies of MMTX by Market Capitalization
Companies near MINDMAZE THERAPEUTICS HOLDING SA in the global market cap rankings as of November 4, 2026. Also see MMTX total assets for a full breakdown of the balance sheet.
Key companies related to MINDMAZE THERAPEUTICS HOLDING SA by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #372 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #411 globally with a market cap of $69.05 Billion USD ( AU$97.59 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #497 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $553.15 |
| #372 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $961.26 |
| #411 | CSL Ltd | AU:CSL | $69.05 Billion | AU$201.16 |
| #497 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $220.83 |
Market Capitalization of MINDMAZE THERAPEUTICS HOLDING SA (2025–2026)
Market capitalization of MINDMAZE THERAPEUTICS HOLDING SA from 2025 to today. Between 2025 and today, MINDMAZE THERAPEUTICS HOLDING SA's market cap moved from $408.34 Million to $ 29.92 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CHF29.92 Million | -92.67% |
| 2025 | CHF408.34 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of MINDMAZE THERAPEUTICS HOLDING SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $28.56 Million USD |
| MoneyControl | $28.56 Million USD |
| MarketWatch | $28.56 Million USD |
| marketcap.company | $28.56 Million USD |
| Reuters | $28.56 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About MINDMAZE THERAPEUTICS HOLDING SA
MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outp… Read more